Skip to content
newsechoasia

newsechoasia

Press Releases, Companye Events, Business News in Asia

Menu
  • Home
  • SeaPRwire
  • ACN
  • JCN
  • EQS
  • Finance
  • Business
  • Instant
  • Contact

Tag: phase

Posted onJanuary 5, 2023

HighTide Therapeutics Raises $107 Million in Series C/C+ Financing to Advance Innovative Pipeline and Business Collaborations

ROCKVILLE, MD and SHENZHEN, CHINA, Jan 5, 2023 – (ACN Newswire via SEAPRWire.com) – HighTide Therapeutics Inc. (“HighTide”), a globally integrated clinical-stage biopharmaceutical company developing…

Read More
Posted onDecember 31, 2022

New it.com Domain Name Goes into Sunrise Phase on 2nd January 2023

London, UK, December 30, 2022 – (SEAPRWire) – UK Intis Telecom LTD announces the launch of the new top-level domain name zone (TLD) – it.com. This new…

Read More
Posted onNovember 22, 2022

Mazda: Mid-Term Management Plan Update and Management Policy up to 2030

HIROSHIMA, Japan, Nov 22, 2022 – (JCN Newswire via SEAPRWire.com) – Mazda Motor Corporation today announces an update to its Mid-Term Management Plan and basic…

Read More
Posted onOctober 12, 2022

80-160 year building use rights in IKN to attract investors: Minister

JAKARTA, Oct 12, 2022 – (ACN Newswire via SEAPRWire.com) – The Ministry of Agrarian and Spatial Planning/National Land Agency (ATR/BPN) is offering building use rights…

Read More
Posted onSeptember 6, 2022

Avance Clinical Announces North American CRO Acquisition to Expand Later Phase Services for Biotechs

SYDNEY, AU, Sep 6, 2022 – (ACN Newswire via SEAPRWire.com) – Avance Clinical, the Australian CRO for biotechs, has expanded into North America with the…

Read More
Posted onAugust 24, 2022

Zhaoke Ophthalmology Announces 2022 Interim Results

HONG KONG, Aug 24, 2022 – (ACN Newswire via SEAPRWire.com) – Zhaoke Ophthalmology Limited (“Zhaoke Ophthalmology” or the “Company”, SEHK: 6622), a leading ophthalmic pharmaceutical…

Read More
Posted onJune 25, 2022

Nakamoto Games Entering New Growth Phase

Play-to-earn disruptor to finalize private sale token distribution ahead of schedule Mahe, Seychelles, June 25, 2022 – (SEAPRWire) -Nakamoto Games ($NAKA), the token powering the industry’s fastest-growing play-to-earn…

Read More
Posted onJune 15, 2022

SinoMab Dosed First Healthy Subject in Phase I Clinical Trial of SM17 in the U.S.

HONG KONG, Jun 15, 2022 – (ACN Newswire via SEAPRWire.com) – SinoMab BioScience Limited (“SinoMab” or the “Company”, together with its subsidiaries, the “Group”, stock…

Read More
Posted onMarch 22, 2022

Essex Bio-Technology Announces 2021 Financial Results

HONG KONG, Mar 22, 2022 – (ACN Newswire via SEAPRWire.com) – Essex Bio-Technology Ltd (“Essex” or the “Group”, Stock Code: 1061.HK) today announced the annual…

Read More
Posted onFebruary 7, 2022

SinoMab Announces IND APPLICATION FOR SN1011 ACCEPTED BY NMPA CDE

HONG KONG, Feb 7, 2022 – (ACN Newswire via SEAPRWire.com) – SinoMab BioScience Limited (“SinoMab” or the “Company”, together with its subsidiaries, the “Group”, stock…

Read More
Posted onJanuary 18, 2022

Avance Clinical Announces Major PE Investment for US Expansion at Biotech Showcase 2022

ADELAIDE, AUS, Jan 18, 2022 – (ACN Newswire via SEAPRWire.com) – Avance Clinical, the largest premium Australian Contract Research Organisation (CRO) for international biotechs, has…

Read More
Posted onJanuary 12, 2022

Phase I Clinical Trial of AIM mRNA COVID-19 Vaccine (LVRNA009) Won the Praise of the Industry for High Safety and Well Tolerance

HANGZHOU, CHINA, Jan 12, 2022 – (ACN Newswire via SEAPRWire.com) – On January 8, AIM Vaccine held a meeting at Shulan (Hangzhou) Hospital to report…

Read More
Posted onDecember 24, 2021

Investigational Alzheimer’s Disease Therapy Lecanemab Granted FDA Fast Track Designation

TOKYO, Dec 24, 2021 – (JCN Newswire via SEAPRWire.com) – Eisai Co., Ltd. and Biogen Inc. announced today that lecanemab, an investigational anti-amyloid beta (Abeta)…

Read More
Posted onNovember 30, 2021

SinoMab Announces the Completion of Enrollment in Phase III Clinical Trial in China for its Flagship Product, SM03

HONG KONG, Nov 30, 2021 – (ACN Newswire via SEAPRWire.com) – SinoMab BioScience Limited (“SinoMab”, or the “Company”, stock code: 3681.HK), a Hong Kong-based biopharmaceutical…

Read More
Posted onNovember 20, 2021

Why the outcomes of the Glasgow climate talks are key for Singapore

SINGAPORE – The annual United Nations climate change conferences may seem far removed from the reality of climate impacts that have upended lives and livelihoods.…

Read More
Posted onNovember 11, 2021

Eisai Presents Late-Breaker Updates on Lecanemab Clinical, Biomarker and Safety Data from Phase 2b Study Core and Open-Label Extension

TOKYO, Nov 11, 2021 – (JCN Newswire via SEAPRWire.com) – Eisai Co., Ltd. and Biogen Inc. announced today results of new clinical, biomarker and safety…

Read More
Posted onNovember 9, 2021

MC and Kinki Sharyo Sign Contract with Egyptian Government for Rolling Stock Deliveries for Phase 1 of Cairo Metro Line 4

TOKYO, Nov 9, 2021 – (JCN Newswire via SEAPRWire.com) – Mitsubishi Corporation (MC) and The Kinki Sharyo Co., Ltd. (Kinki Sharyo) are pleased to announce…

Read More
Posted onSeptember 17, 2021

SinoMab, Sinovent and Everest Medicines Announce Licensing Agreement for Global Development and Commercialization of A Next-Generation BTK Inhibitor in Renal Diseases

HONG KONG, Sep 17, 2021 – (ACN Newswire via SEAPRWire.com) – SinoMab BioScience Limited (HKEX 3681.HK, “SinoMab”) announced with Suzhou Sinovent Pharmaceuticals Co., Ltd. (“Sinovent”)…

Read More
Posted onSeptember 7, 2021

Bit2Me Raises 5 Million Euros as Phase One of ICO Sells Out in Under 60 Seconds

MADRID, Sep 7, 2021 – (ACN Newswire via SEAPRWire.com) – Bit2Me has closed the first phase of its ICO (Initial Coin Offering) in just 59…

Read More
Posted onAugust 30, 2021

Kintor Pharma Announces 2021 Interim Results

SUZHOU, CHINA, Aug 30, 2021 – (ACN Newswire via SEAPRWire.com) – Kintor Pharmaceutical Limited (“Kintor Pharma”, HKEX: 9939), a clinical-stage biotechnology company developing innovative small…

Read More

Posts navigation

Page 1 Page 2 Next Page

目录导航

  • 首页
  • SeaPRwire
  • ACN Newswire
  • JCN Newswire
  • EQS Newswire
  • 商业新闻
  • 财经新闻
  • 即时热闻
  • 联络我们
  • 关于我们
  • RSS

Singapore News

  • Among Migrating Nurses, Survey Shows High Satisfaction Rates for Those Who Use a Certified Ethical Recruiter September 11, 2025
  • 哈马斯策划渗透美国支持的加沙援助点,迫使其暂时关闭 September 11, 2025
  • 值得关注的创新科技股 September 11, 2025
  • 查理·柯克因坚定支持获加沙人质家属哀悼 September 11, 2025
  • The Sixth Bosum Private Enterprise Gala Concludes Successfully, Bosum AI Agent Debuts, and Industry Leaders Set New Directions for Innovation September 11, 2025
  • Doubleview Gold Corp Announces Important High-Grade Copper and Gold Intercepts at Hat Polymetallic Deposit in Northwestern British Columbia September 11, 2025
  • 英国驻美国大使因与爱泼斯坦的关系遭解职 September 11, 2025
  • Envirosite 扩展至澳大利亚,收购 Land Insight 资产 September 11, 2025
  • The 10th Belt and Road Summit concludes successfully September 11, 2025
  • Intel的定制芯片策略 September 11, 2025
  • CO2NNEX(R) Digital Platform for Transfer and Management of e-Methane Clean Gas Certificates to Be Utilized in Nagaoka Methanation Demonstration September 11, 2025
  • 专家警告:9/11事件24年后,Al Qaeda 仍然是最危险的恐怖组织 September 11, 2025
  • Hitachi accelerates growth with major U.S. investments in advanced manufacturing, electrification and workforce development September 11, 2025
  • GlobalLogic and Ericsson Deploy Private 5G Network at Hitachi Rail’s State-of the-Art Digital Factory September 11, 2025
  • A Sparkling New Chapter: Spritzer’s First-Ever Mini-Drama Series Stars New Brand Ambassador Anna Jobling September 11, 2025

Links

  • YAHOO
  • NASDAQ
  • Bloomberg
  • Newswire
  • EastMud
  • AsiaEase
  • NetDace
  • PostVN
  • VOASG
  • EventPH
© Copyright 2024 – NewsEchoAsia